Practice Guidelines on NAFLD

نویسنده

  • Melissa Palmer
چکیده

To The Editor: I read with interest the practice guidelines on nonalcoholic fatty liver disease (NAFLD), 1 in which the authors fail to reference the association between high fructose corn syrup (HFCS) and NAFLD. The intake of HFCS, a combination of glucose and fructose, has increased over time and parallels both the obesity and NAFLD epidemics. 2 Numerous studies demonstrate that the mechanism by which HFCS causes NAFLD is due to fructose. In animal models, fructose causes steatosis and fibrosis 3,4 by either increasing hepatic lipogenesis, causing activation of pyruvate dehydrogenase, 5 activating inflammatory pathways, 6 or up-regulating the expression of sterol regulatory element-binding protein (SREBP). 7 In humans, excessive fructose intake can lead to increased hepatic lipid deposition, greater insulin resistance, and hypertriglyceridemia. 8 NAFLD patients have been found to drink more HFCS soft drinks compared with healthy controls. 9 A retrospective analysis of 341 NAFLD adults found that those consuming high fructose diets had more fibrosis than those consuming low fructose diets. 10 A prospective controlled trial with histologic endpoints is needed to define the amount of HFCS safe for NAFLD patients and to determine the extent to which fructose contributes to the pathogenesis and progression of NAFLD. However, there are currently sufficient data to recommend that NAFLD patients refrain from excessive consumption of HFCS. Effects of dietary fructose on liver steatosis in overfed mule ducks. Mechanisms of fructose-induced hypertriglyceridaemia in the rat. Activation of hepatic pyruvate dehydrogenase through inhibition of pyru-vate dehydrogenase kinase. On behalf of my coauthors, I thank Dr. Melissa Palmer, a respected hepatologist, for her interest in the multisociety practice guideline on the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) that was published in the June 2012 issue of Hepatology. 1 Dr. Palmer raises an important issue about the role of fructose and high-fructose corn syrup (HFCS) in the pathogenesis of NAFLD. Dr. Palmer cites several publications that have shown an adverse role for fructose in the experimental models of NAFLD. We do not dispute these published data, but we would like to point out a publication in this journal that argues against a singular role for a high fructose diet in the pathogenesis of NAFLD. 2 Lee et al. showed that although Ossabaw swine fed a high-calorie and high-fructose diet for 24 weeks developed obesity, glucose intolerance, and hyper-tension, there was no evidence of abnormal liver biochemistries or steatohepatitis until high …

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists.

INTRODUCTION Nonalcoholic fatty liver disease (NAFLD) has an increasing incidence worldwide, reflecting the epidemics of obesity and metabolic syndrome. Data on knowledge, attitude and management by the Romanian gastroenterologists with regard to NAFLD are lacking. METHODS We assessed current diagnostic and treatment patterns of the management of NAFLD among 102 Romanian board certified gastr...

متن کامل

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Until recently, the major causes of end-stage liver disease in Korea were chronic hepatitis B virus (HBV) and chronic hepatitis C virus (HCV) infections and alcoholic liver disease. However, hepatitis B vaccinations and antiviral drugs are anticipated to significantly reduce end-stage liver disease caused by hepatitis viruses. In contrast, the incidence of obesity-related metabolic syndrome has...

متن کامل

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

The Clinical Practice Guidelines (CPG) propose recommendations for the diagnosis, treatment and follow-up of non-alcoholic fatty liver disease (NAFLD) patients and are the product of a joint effort by the European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO). They update a position s...

متن کامل

Clinical guidelines of non-alcoholic fatty liver disease: A systematic review

AIM To perform a systematic review to grade guidelines and present recommendations for clinical management of non-alcoholic fatty liver disease (NAFLD). METHODS A database search was conducted on PubMed for guidelines published before May 2016, supplemented by reviewing relevant websites. The Appraisal of Guidelines for Research and Evaluation (ARGEE) Instrument II was a tool designed to appr...

متن کامل

Nonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis

Nonalcoholic fatty liver disease (NAFLD) is a pathologic condition frequently observed in clinical practice. To date, the prevalence of NAFLD is approximately 25-30% among adults of the general population in Western countries but increases to approximately 70-75% among patients with type 2 diabetes mellitus. In the last decade, accumulating evidence has clearly demonstrated that patients with N...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 57  شماره 

صفحات  -

تاریخ انتشار 2013